Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts, Debridement & negative-pressure wound therapy.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Convatec (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2018 (2). The latest was on 2018-10-19.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 7 |
| Debridement & negative-pressure wound therapy | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2018-10-19 | 510(k) | K180205 | AVELLE Negative Pressure Wound Therapy System |
| 2018-07-20 | 510(k) | K173675 | AQUACEL Ag+ EXTRA Enhanced Hydrofiber Dressing with Silver and Strengthening Fiber |
| 2016-01-21 | 510(k) | K152926 | AQUACEL Ag Surgical SP Dressing |
| 2013-06-06 | 510(k) | K123481 | AQUACEL AG FOAM HYDROFIBER FOAM DRESSING WITH SILVER, ADHESIVE AND NON ADHESIVE |
| 2012-07-25 | 510(k) |
In 2025, Convatec reported engagement with 5,642 surgeons and other clinicians in the states MedaRep covers, worth $1.3M in consulting, speaking, meals and travel for its device products, the most in Indiana ($202K to 122). Royalties are left out.
| K121275 |
| AQUACEL AG EXTRA HYDROFIBER DRESSING WITH SILVER AND STRENGTHENING FIBER |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Convatec.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Indiana ($202K, 122 engaged), Florida ($171K, 587 engaged), Delaware ($121K, 16 engaged), Kansas ($93K, 68 engaged), Missouri ($88K, 147 engaged).